Natera, Inc., a global leader in cell-free DNA testing, announced earlier at the Canaccord Genuity 42nd Annual Growth Conference in Boston that the company...
Fluidx Medical disclosed study results examining extent of vessel filling using the GPX Embolic Device compared to microspheres, a common treatment for many types...
Roche announced US Food and Drug Administration (FDA) approval of a label expansion for the VENTANA MMR RxDx Panel. This approval advances the company's...
